Coherus BioSciences, Inc. (NASDAQ:CHRS)

CAPS Rating: 2 out of 5

Results 1 - 1 of 1

Recs

1
Member Avatar murphydevani (70.41) Submitted: 8/21/2015 9:08:55 AM : Underperform Start Price: $28.55 CHRS Score: +36.33

Target $27 - $25 - $21

Results 1 - 1 of 1

Featured Broker Partners